(Total Views: 377)
Posted On: 06/30/2021 7:20:44 PM
Post# of 148908
Re: Northstar42 #94788
Well only one dude was quoted in his hiring PR and it wasn’t NP. You do the math…
Quote:
“Richard is a driving force in CCR5 antagonist research and we gain significant expertise and intellectual property with this acquisition that advances the development of PRO 140 as a novel cancer metastasis therapeutic,” said Anthony D. Caracciolo, CytoDyn’s Chairman. “We are privileged to have Richard join CytoDyn to expand our executive and scientific team, and we enthusiastically welcome him as the newest member of our board of directors.”
(7)
(0)Scroll down for more posts ▼
